From the weekly letter · 16 November 2026

Why cover this story this week?

When mitochondrial trouble activates the wrong defence

Mitochondrial failure can provoke antiviral responses even without a viral infection. In mice and human brain organoids modeling Leigh syndrome, researchers found an antiviral programme in vulnerable inhibitory neurons. But removing the interferon receptor Ifnar1 or the immune-signalling mediator Sting1 did not improve disease progression. Another sensor, protein kinase R, or PKR, proved more consequential: it associated with mitochondrial RNA, and deleting or silencing it delayed neurological decline, reduced neuroinflammation and extended survival.

Those benefits occurred without restoring mitochondrial respiration. PKR deletion also normalized JNK signalling without detectable global repression of protein translation, suggesting a route beyond PKR’s familiar role in shutting down protein production. The preprint separates an immune response that accompanies disease from a component that helps drive it. It points towards modifying the damaging response to an energy defect, while leaving the underlying respiratory failure unresolved.

Editorial context written by AI from abstracts, not independent scientific validation. The kit and its verified quotes rely on the source paper, not on this letter.

Read the full letter →

Talk about a paper in public without overstating it: yours, one you are asked to comment on, or one you write about as a journalist.

  • Your paper: a draft release for your press office, the questions journalists will ask with what the paper lets you answer, the likely misreadings, a lay summary and a short thread.
  • Asked to comment: what the paper shows and does not, its strengths and weaknesses with their passages, and what would settle its main claim.
  • Writing about it as a journalist: reporting angles, the wording to check before publication, and the questions to ask the authors.
  • For everyone: findings with their passages checked word for word, the novelty set against the closest earlier papers, a hype check, figures with their credit, and researchers for an outside view who have not signed with the authors.

Discover Premium+ See an example kit